All news

Two firms report a 3.34% Radiopharm Theranostics (RADX) stake with shared voting power

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Regal Partners Funds Management Pty Limited and Regal Partners Limited have reported a 3.34% beneficial ownership stake in Radiopharm Theranostics Ltd (RADX), totaling 157,139,443 shares. This stake includes both ordinary shares and American Depositary Shares, with both entities holding shared voting and dispositive power over the entire position.

Read original source

RADX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.